SK4 calcium-activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute stroke

Background: New-onset atrial fibrillation (AF) is common in patients with acute stroke (AS). Studies have shown that intermediate-conductance calcium-activated potassium channel channels (SK4) play an important role in cardiomyocyte automaticity. The aim of this study was to investigate the effects...

Full description

Bibliographic Details
Main Authors: Mei Yang, Youcheng Wang, Xiaoxing Xiong, Baojun Xie, Jia Liu, Junkui Yin, Liuliu Zi, Xi Wang, Yanhong Tang, Congxin Huang, Qingyan Zhao
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844020307738
_version_ 1818304680397111296
author Mei Yang
Youcheng Wang
Xiaoxing Xiong
Baojun Xie
Jia Liu
Junkui Yin
Liuliu Zi
Xi Wang
Yanhong Tang
Congxin Huang
Qingyan Zhao
author_facet Mei Yang
Youcheng Wang
Xiaoxing Xiong
Baojun Xie
Jia Liu
Junkui Yin
Liuliu Zi
Xi Wang
Yanhong Tang
Congxin Huang
Qingyan Zhao
author_sort Mei Yang
collection DOAJ
description Background: New-onset atrial fibrillation (AF) is common in patients with acute stroke (AS). Studies have shown that intermediate-conductance calcium-activated potassium channel channels (SK4) play an important role in cardiomyocyte automaticity. The aim of this study was to investigate the effects of SK4 on AF vulnerability in dogs with AS. Experimental: Eighteen dogs were randomly divided into a control group, AS group and left stellate ganglion ablation (LSGA) group. In the control group, dogs received craniotomy without right middle cerebral artery occlusion (MCAO). AS dogs were established using a cerebral ischemic model with right MCAO. LSGA dogs underwent MCAO, and LSGA was performed. Results: Three days later, the dispersion of the effective refractory period (dERP) and AF vulnerability in the AS group were significantly increased compared with those in the control group and LSGA group. However, no significant difference in dERP and AF vulnerability was found between the control group and the LSGA group. The SK4 inhibitor (TRAM-34) completely inhibited the inducibility of AF in AS dogs. SK4 expression and levels of noradrenaline (NE), β1-AR, p38 and c-Fos in the atrium were higher in the AS dogs than in the control group or LSGA group. However, no significant difference in SK4 expression or levels of NE, β1-AR, p38 and c-Fos in the left atrium was observed between the control group and LSGA group. Conclusion: SK4 plays a key role in AF vulnerability in a canine model with AS. The effects of LSGA on AF vulnerability were associated with the p38 signaling pathways.
first_indexed 2024-12-13T06:14:33Z
format Article
id doaj.art-79180dfa8c35440785c4a5c43db449da
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-12-13T06:14:33Z
publishDate 2020-05-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-79180dfa8c35440785c4a5c43db449da2022-12-21T23:57:00ZengElsevierHeliyon2405-84402020-05-0165e03928SK4 calcium-activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute strokeMei Yang0Youcheng Wang1Xiaoxing Xiong2Baojun Xie3Jia Liu4Junkui Yin5Liuliu Zi6Xi Wang7Yanhong Tang8Congxin Huang9Qingyan Zhao10Department of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Hubei Key Laboratory of Cardiology, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Hubei Key Laboratory of Cardiology, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR ChinaDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan City, 430060, PR ChinaDepartment of Radiology, Renmin Hospital of Wuhan University, Wuhan City, 430060, PR ChinaDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan City, 430060, PR ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Hubei Key Laboratory of Cardiology, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Hubei Key Laboratory of Cardiology, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Hubei Key Laboratory of Cardiology, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Hubei Key Laboratory of Cardiology, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Hubei Key Laboratory of Cardiology, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Cardiovascular Research Institute of Wuhan University, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Hubei Key Laboratory of Cardiology, 238 Jiefang Road, Wuchang, Wuhan City, 430060, PR China; Corresponding author.Background: New-onset atrial fibrillation (AF) is common in patients with acute stroke (AS). Studies have shown that intermediate-conductance calcium-activated potassium channel channels (SK4) play an important role in cardiomyocyte automaticity. The aim of this study was to investigate the effects of SK4 on AF vulnerability in dogs with AS. Experimental: Eighteen dogs were randomly divided into a control group, AS group and left stellate ganglion ablation (LSGA) group. In the control group, dogs received craniotomy without right middle cerebral artery occlusion (MCAO). AS dogs were established using a cerebral ischemic model with right MCAO. LSGA dogs underwent MCAO, and LSGA was performed. Results: Three days later, the dispersion of the effective refractory period (dERP) and AF vulnerability in the AS group were significantly increased compared with those in the control group and LSGA group. However, no significant difference in dERP and AF vulnerability was found between the control group and the LSGA group. The SK4 inhibitor (TRAM-34) completely inhibited the inducibility of AF in AS dogs. SK4 expression and levels of noradrenaline (NE), β1-AR, p38 and c-Fos in the atrium were higher in the AS dogs than in the control group or LSGA group. However, no significant difference in SK4 expression or levels of NE, β1-AR, p38 and c-Fos in the left atrium was observed between the control group and LSGA group. Conclusion: SK4 plays a key role in AF vulnerability in a canine model with AS. The effects of LSGA on AF vulnerability were associated with the p38 signaling pathways.http://www.sciencedirect.com/science/article/pii/S2405844020307738NeuroscienceCardiovascular systemCirculatory systemPharmacologyInternal medicineLaboratory medicine
spellingShingle Mei Yang
Youcheng Wang
Xiaoxing Xiong
Baojun Xie
Jia Liu
Junkui Yin
Liuliu Zi
Xi Wang
Yanhong Tang
Congxin Huang
Qingyan Zhao
SK4 calcium-activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute stroke
Heliyon
Neuroscience
Cardiovascular system
Circulatory system
Pharmacology
Internal medicine
Laboratory medicine
title SK4 calcium-activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute stroke
title_full SK4 calcium-activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute stroke
title_fullStr SK4 calcium-activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute stroke
title_full_unstemmed SK4 calcium-activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute stroke
title_short SK4 calcium-activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute stroke
title_sort sk4 calcium activated potassium channels activated by sympathetic nerves enhances atrial fibrillation vulnerability in a canine model of acute stroke
topic Neuroscience
Cardiovascular system
Circulatory system
Pharmacology
Internal medicine
Laboratory medicine
url http://www.sciencedirect.com/science/article/pii/S2405844020307738
work_keys_str_mv AT meiyang sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT youchengwang sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT xiaoxingxiong sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT baojunxie sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT jialiu sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT junkuiyin sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT liuliuzi sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT xiwang sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT yanhongtang sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT congxinhuang sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke
AT qingyanzhao sk4calciumactivatedpotassiumchannelsactivatedbysympatheticnervesenhancesatrialfibrillationvulnerabilityinacaninemodelofacutestroke